Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01162564 · ClinicalTrials.gov registry record

Flexible Composite Next Generation Tissue Separating Mesh in Laparoscopic Incisional/Ventral Hernia Repair

A clinical trial of Ventral Hernia and Incisional Hernia, sponsored by Ethicon.

Completed
Registry status
48
Enrollment target
6
Study locations

NCT01162564: Completed study of Ventral Hernia and Incisional Hernia, sponsored by Ethicon.

NCT01162564 is a study of Ventral Hernia and Incisional Hernia that has completed, run by Ethicon. The registered enrollment target is 48 participants, below the 140-participant average among 18 other Ventral Hernia trials with a reported enrollment target (66% lower). The trial reports 6 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01162564, a study of Ventral Hernia and Incisional Hernia, has completed, sponsored by Ethicon.

COMPLETED
Registry status
48 participants
Enrollment target
6
Study locations

Study Summary

This is a multi-center, observational study of incisional/ventral hernia repair with NG-TSM laparoscopically. The study is not randomized and has a single treatment design assessing NG-TSM intra-operatively, its ease of use and handling characteristics.

Interventions

  • DEVICE NG-TSM

Study Locations (6)

Missouri

  • Capital Region Hospital - Jefferson City
  • Washington University School of Medicine / Dept of Surgery - St Louis

North Carolina

  • First Health Moore Regional Hospital - Pinehurst
  • New Hanover Regional Hospital - Wilmington

New York

  • Montefiore Medical Center - The Bronx

Virginia

  • Eastern Virginia Medical School - Norfolk

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2010-06
Est. Completion 2011-01
Ethicon

38 total trials

What the finished NCT01162564 record still lists

NCT01162564 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 140-participant average among 18 other Ventral Hernia trials with a reported enrollment target (66% lower).

The record links to 2 conditions, with Ventral Hernia appearing as the primary indexed condition, and to 1 intervention - of which NG-TSM is the first listed.

NCT01162564 lists 6 locations in 4 states (Missouri, North Carolina, New York).

Frequently Asked Questions

What is clinical trial NCT01162564 about?

NCT01162564 is a clinical study titled "Flexible Composite Next Generation Tissue Separating Mesh in Laparoscopic Incisional/Ventral Hernia Repair". This is a multi-center, observational study of incisional/ventral hernia repair with NG-TSM laparoscopically. The study is not randomized and has a single treatment design assessing NG-TSM intra-operatively, its ease of use and handling characteristics.

What is the current status of trial NCT01162564?

This trial is currently completed. The enrollment target is 48 participants. The study started on 2010-06. Estimated completion is 2011-01.

What conditions does trial NCT01162564 study?

This clinical trial studies the following conditions: Ventral Hernia, Incisional Hernia.

What interventions are being tested in trial NCT01162564?

The interventions under investigation include: NG-TSM (DEVICE).

Who is sponsoring clinical trial NCT01162564?

This trial is sponsored by Ethicon, which has 38 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01162564 being conducted?

This trial has 6 study locations across Missouri, New York, North Carolina, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ventral Hernia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01162564's enrollment target sits among peer trials

48 16th of 18 higher than 3 of 18 other Ventral Hernia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Ventral Hernia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01765777 · 48 participants · NA

    Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain

  • NCT03073343 · 48 participants · NA

    A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

  • NCT03431064 · 48 participants

    Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients

  • NCT03514602 · 48 participants · NA

    Maternal Smoking Cessation and Pediatric Obesity Prevention

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01162564, the US trial registry maintained by the National Library of Medicine. NCT01162564 (small enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.